Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target

Open access
Kennedy, Cassandra R., Goya Grocin, Andrea, Kovačič, Tristan, Singh, Ravi, Ward, Jennifer A., Shenoy, Avinash R., Tate, Edward W. · 2021 · ACS Chemical Biology

Abstract

High Resolution Image Download MS PowerPoint Slide Inhibition of inflammasome and pyroptotic pathways are promising strategies for clinical treatment of autoimmune and inflammatory disorders. MCC950, a potent inhibitor of the NLR-family inflammasome pyrin domain-containing 3 (NLRP3) protein, has shown encouraging results in animal models for a range of conditions; however, until now, no off-targets have been identified. Herein, we report the design, synthesis, and application of a novel photoaffinity alkyne-tagged probe for MCC950 ( IMP2070 ) which shows direct engagement with NLRP3 and inhibition of inflammasome activation in macrophages. Affinity-based chemical proteomics in live macrophages identified several potential off-targets, including carbonic anhydrase 2 (CA2) as a specific target of IMP2070, and independent cellular thermal proteomic profiling revealed stabilization of CA2 by MCC950. MCC950 displayed noncompetitive inhibition of CA2 activity, confirming carbonic anhydrase as an off-target class for this compound. These data highlight potential biological mechanisms through which MCC950 and derivatives may exhibit off-target effects in preclinical or clinical studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acschembio.1c00218

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Design of IMP2070, a photoaffinity probe for target identification for MCC950, a potent inhibitor of NLRP3 inflammasome activation. (a) NLRP3 canonical inflammasome activation in macrophages occurs through a two-step process. A priming stimulus triggers up-regulation of key inflammatory genes before an activating signal triggers inflammasome formation, which enables activation of caspase-1. Caspase-1 cleaves pro-IL-1β, pro-IL-18, and GSDMD into their active forms, triggering GSDMD pore formation, inflammatory cytokine release, and cell lysis. (b) Structures of NLRP3 inflammasome inhibitor MCC950 and IMP2070 AfBP (affinity-based probe). (c) Inhibition of LPS and nigericin induced cell death in THP1-derived macrophages by MCC950 and IMP2070. Results are representative of two experiments; error bars represent SD (n = 3). MCC950: IC50 = 0.2 μM; slope = −1.66; R2 = 0.98. IMP2070: IC50 = 2.7 μM; slope = −1.94; R2 = 0.97.
Figure 1 Design of IMP2070, a photoaffinity probe for target identification for MCC950, a potent inhibitor of NLRP3 inflammasome activation. (a) NLRP3 canonical inflammasome activation in macrophages occurs through a two-step process. A priming stimulus triggers up-regulation of key inflammatory genes before an activating signal triggers inflammasome formation, which enables activation of caspase-1. Caspase-1 cleaves pro-IL-1β, pro-IL-18, and GSDMD into their active forms, triggering GSDMD pore formation, inflammatory cytokine release, and cell lysis. (b) Structures of NLRP3 inflammasome inhibitor MCC950 and IMP2070 AfBP (affinity-based probe). (c) Inhibition of LPS and nigericin induced cell death in THP1-derived macrophages by MCC950 and IMP2070. Results are representative of two experiments; error bars represent SD (n = 3). MCC950: IC50 = 0.2 μM; slope = −1.66; R2 = 0.98. IMP2070: IC50 = 2.7 μM; slope = −1.94; R2 = 0.97.CC BY-NC-ND · PubMed Central
Figure 2 IMP2070 is an MCC950-competitive probe and inhibitor of NLRP3-mediated pyroptosis, and directly cross-links to NLRP3 in intact cells during inflammasome activation. (a) Western blot analysis of caspase-1 and IL-1β in the supernatants and lysates of THP1-derived macrophages. (b) Workflow diagram for photoaffinity based protein profiling with proteomics analysis. Macrophages were treated with IMP2070, and inflammasome activators before UV irradiation generate a carbene from the diazirine. Probe-cross-linked proteins can be further functionalized through copper(I)-catalyzed alkyne–azide cycloaddition before analysis by fluorescence or mass spectrometry. The gray ball represents the specificity region of the AfBP. (c) In-gel fluorescence and western blot analysis of IMP2070-enriched proteins. Results are representative of three experiments. S = supernatant; L = lysate; I = input (whole lysate); P = pull down (enriched fraction). Uncropped blots and gels can be seen in Figures S3 and S4.
Figure 2 IMP2070 is an MCC950-competitive probe and inhibitor of NLRP3-mediated pyroptosis, and directly cross-links to NLRP3 in intact cells during inflammasome activation. (a) Western blot analysis of caspase-1 and IL-1β in the supernatants and lysates of THP1-derived macrophages. (b) Workflow diagram for photoaffinity based protein profiling with proteomics analysis. Macrophages were treated with IMP2070, and inflammasome activators before UV irradiation generate a carbene from the diazirine. Probe-cross-linked proteins can be further functionalized through copper(I)-catalyzed alkyne–azide cycloaddition before analysis by fluorescence or mass spectrometry. The gray ball represents the specificity region of the AfBP. (c) In-gel fluorescence and western blot analysis of IMP2070-enriched proteins. Results are representative of three experiments. S = supernatant; L = lysate; I = input (whole lysate); P = pull down (enriched fraction). Uncropped blots and gels can be seen in Figures S3 and S4.CC BY-NC-ND · PubMed Central
Figure 3 Global target identification for MCC950 combining photoaffinity and thermal proteome profiling, and identification of carbonic anhydrase 2 (CA2) as a major MCC950 off-target. Photoaffinity labeling experiments with IMP2070 highlighted several proteins as significant hits (blue) with (a) 1.0 μM (FC = 1.41; p-value = 0.01), and (b) 5.0 μM IMP2070 (FC = 1.41; p-value = 0.01). Background from known diazirine binders is shown in red. (c) Competition photoaffinity labeling experiments with IMP2070 and MCC950 identified CA2 as an MCC950 binding protein. (d) Thermal protein profiling in whole cells with 0–10 μM MCC950 showed CA2 stabilization with MCC950 at 50.5 and 54 °C. Fumarate hydrase (FH) is shown as an example of a protein not stabilized by the presence of MCC950.
Figure 3 Global target identification for MCC950 combining photoaffinity and thermal proteome profiling, and identification of carbonic anhydrase 2 (CA2) as a major MCC950 off-target. Photoaffinity labeling experiments with IMP2070 highlighted several proteins as significant hits (blue) with (a) 1.0 μM (FC = 1.41; p-value = 0.01), and (b) 5.0 μM IMP2070 (FC = 1.41; p-value = 0.01). Background from known diazirine binders is shown in red. (c) Competition photoaffinity labeling experiments with IMP2070 and MCC950 identified CA2 as an MCC950 binding protein. (d) Thermal protein profiling in whole cells with 0–10 μM MCC950 showed CA2 stabilization with MCC950 at 50.5 and 54 °C. Fumarate hydrase (FH) is shown as an example of a protein not stabilized by the presence of MCC950.CC BY-NC-ND · PubMed Central
Figure 4 Biochemical validation of MCC950 as a noncompetitive inhibitor of carbonic anhydrase 2 (CA2). (a) Residual esterase enzyme activity of CA2 when treated with MCC950. Error bars represent SEM, N = 3. IC50 = 11 μM; slope = −1.47, R2 = 0.99. (b) Hanes-Woolf plot assessing CA2 (85 nM) esterase activity in the presence of MCC950 (1–100 μM) and p-NPA (0.125–1 mM). Error bars represent SEM, N = 3. (Slope, R2) for each MCC950 concentration: 100 μM (3.17, 0.94); 40 μM (9.51, 0.95); 16 μM (20.19, 0.96); 6.4 μM (26.55, 0.95); 2.56 μM (31.74, 0.96); 1.02 μM (33.59, 0.95); DMSO (29.03, 0.96). (c) Molecular docking of MCC950 against CA2 (PDB 3QYK) predicted MCC950 (cyan) interactions with the catalytic zinc (gray), and occupation of the protein pocket similar to 4-(7-methylpyrazolo[3′,4′:4,5]thiopyrano[2,3-b]pyridin-1(4H)-yl)benzenesulfonamide (green). Oxygens are shown in red, sulfur in yellow, and nitrogen in dark blue. (d) Predicted interactions between MCC950 (black) and CA2 residues (blue) and zinc (gray).
Figure 4 Biochemical validation of MCC950 as a noncompetitive inhibitor of carbonic anhydrase 2 (CA2). (a) Residual esterase enzyme activity of CA2 when treated with MCC950. Error bars represent SEM, N = 3. IC50 = 11 μM; slope = −1.47, R2 = 0.99. (b) Hanes-Woolf plot assessing CA2 (85 nM) esterase activity in the presence of MCC950 (1–100 μM) and p-NPA (0.125–1 mM). Error bars represent SEM, N = 3. (Slope, R2) for each MCC950 concentration: 100 μM (3.17, 0.94); 40 μM (9.51, 0.95); 16 μM (20.19, 0.96); 6.4 μM (26.55, 0.95); 2.56 μM (31.74, 0.96); 1.02 μM (33.59, 0.95); DMSO (29.03, 0.96). (c) Molecular docking of MCC950 against CA2 (PDB 3QYK) predicted MCC950 (cyan) interactions with the catalytic zinc (gray), and occupation of the protein pocket similar to 4-(7-methylpyrazolo[3′,4′:4,5]thiopyrano[2,3-b]pyridin-1(4H)-yl)benzenesulfonamide (green). Oxygens are shown in red, sulfur in yellow, and nitrogen in dark blue. (d) Predicted interactions between MCC950 (black) and CA2 residues (blue) and zinc (gray).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 81

Metadata

Authors
Kennedy, C. R., Goya Grocin, A., Kovačič, T., Singh, R., Ward, J. A., Shenoy, A. R., & Tate, E. W.
Affiliations
  • Imperial College London (GB)
  • Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, United Kingdom
  • The Francis Crick Institute (GB)
Corresponding author
  • Shenoy, Avinash R.
  • Tate, Edward W.
Venue
ACS Chemical Biology
Published
2021-05-18
Volume
16
Issue
6
Pages
982-990
ISSN
  • 1554-8929 (ISSN-L)
  • 1554-8937
OpenAlex
W3160057429
Cited by
81
References
33
Citations by year
2026: 27 · 2025: 18 · 2024: 15 · 2023: 11 · 2022: 7 · 2021: 3
FWCI
2.81
Type
journal article
Language
en
Open access
Locations
  • ACS Chemical Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
  • Engineering and Physical Sciences Research Council (EP/L015498/1)
  • Medical Research Council (MR/P022138/1)
  • Wellcome Trust (108246/Z/15/Z)
  • Cancer Research UK (C29637/A20183, C29637/A21451)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
  • Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
Keywords
MCC950, NLRP3 inflammasome, carbonic anhydrase II, off-target effects, photoaffinity probes, chemoproteomics, macrophages, pyroptosis, non-competitive inhibition, drug target identification
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Cell Line, Enzyme Inhibitors, Furans, Humans, Indenes, Macrophages, Models, Molecular, Sulfonamides, Carbonic Anhydrase II, Proteomics, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target. https://app.cochat.ai/papers/10.1021/acschembio.1c00218
The paper
Kennedy, C. R., Goya Grocin, A., Kovačič, T., Singh, R., Ward, J. A., Shenoy, A. R., & Tate, E. W. (2021). A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target. ACS Chemical Biology. https://doi.org/10.1021/acschembio.1c00218

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.